Annual Report 2012

Introduction
The International Medical School 2020 project (IMS 2020) aims to harness the ever growing momentum of internationalization in medical training and research and channel this into a quality label that will measure levels of internationalization at medical schools worldwide thus identifying leading international medical schools. In addition and in preparation for this label, IMS 2020 has been developing specialized staff training courses (STCs) for applicant institutions. The IMS 2020 Project is coordinated by the Charité University Hospital in Berlin (Charité Universitätsmedizin Berlin). The project has nine project partners including six prominent European medical schools (Charité Universitätsmedizin Berlin, Université Paris Descartes, University of Antwerp, Sapienza Università di Roma, Karolinska Institutet, Medical University of Warsaw), one Australian medical school (Monash University) and two advisory partners (Brussels Education Services and CHE Consult). Working together in the last two years the three project task forces (TFs) have established a label methodology design and a first indicator catalogue is nearing completion. Additionally six exemplary local STCs focusing on internationalization in medical teaching and research were held in spring 2012. A database of these STCs should be available to label applicants by the end of the project period. Now, in autumn 2012 the third and final project year is about to commence. With the label methodology finished and indicators reaching completion, IMS 2020 has entered into talks with the M8 Alliance with the aim of introducing the label to the international medical field on a larger and more influential platform. It is hoped that the application process for label accreditation will commence in autumn 2013. Actual label accreditation will be based on a 15 month accreditation phase. This annual report details the work of the three project task forces to date and IMS 2020 aims in the final project year and beyond.

Task Force 1 ‘Quality Assurance’
Task Force Background In the second year of the project Task Force 1 (TF1) continued its work on developing the IMS label methodology draft. A document defining the label’s foundation (purpose, philosophy, goals, dimensions, filter criteria) has been finalized which precisely describes the entire labelling process (phases, applicable methods and evaluation tools). In particular an IMS label glossary has been prepared which defines all terms used in the label. Thus the main achievements of the TF at the end of the second project year include: a) Completion of the IMS label methodology draft b) Completion of the IMS label glossary c) Completion of the IMS label tool for collection and analysis of quantitative data Simultaneously, a fundamental tool for collection and analysis of quantitative data has been carefully designed, tested and ratified. This is necessary for the evaluation of the medical school’s level and quality of internationality and internationalization. The toolbox will gather: a) The desirable benchmarks and real three year period data for quantitative indicators related to the six IMS label dimensions (institution, students, staff, research, curriculum, social engagement): From the available 80 indicators , an applicant school needs to choose at least 50% per dimension to self-evaluate its performance b) Background information; This will mean that the quantitative data provided by the medical school can be considered in the relevant context (its chosen profile of internationality and scope of the label) By the end of the second project year and based on the use of this tool we will finish collecting data from the six university medical school project partners. TF Aims and Plans for the 3rd Project Year After analysing the data gathered from the university project partners TF1 will use the third project year to: a) Finalize the IMS label toolbox b) Conduct the full IMS labelling process at interested university project partners c) Deliver the IMS label to external stakeholders The main task for TF1 will be to run the full labelling process at selected medical schools, including expert data analysis and to conduct peer review visits. In this way we hope to grant first IMS labels and at the same time plan to test and validate the IMS label methodology and tools in practice. As a consequence, at the end of the project, we hope to be able to provide medical schools worldwide with a comprehensive and reliable label, which recognizes, supports and rewards excellence in the area of internationalization. Drafted by the Co-Head of TF1: Joanna Gajowniczek (Warsaw)

Task Force 2 ‘Staff Management & Training’
Task Force Background Task Force 2 (TF2) is headed by the Charité University Medical School in Berlin. The TF focuses on developing Staff Training Courses (STCs) transporting locally relevant and centrally developed ideas on internationalization management and (inter)cultural awareness in medical education, research supervision and administration to relevant medical school staff. To date the audience for the STCs includes doctors, researcher supervisors and administrative staff at partner medical schools. Thus, in year 2 the main aims of the TF were twofold. Firstly TF2 had to get the local STCs up and running at partner institutions. And secondly towards the end of the year the TF had to use course feedback and evaluations to refine the course structure with the hope of establishing permanent STCs at the university partner institutions in project year 3. These aims have been successfully achieved. Local STCs were held at partner medical schools in Rome, Berlin, Paris, Stockholm, Antwerp and Warsaw in March/April 2012 and a document summarizing evaluations has been drafted. TF Aims and Plans for the 3rd Project Year A TF 2 feedback meeting will be held on the 18th Oct. 2012. At this meeting an evaluation of work to date will be carried out and a set of guidelines based on TF results will be discussed (the guidelines will be written in the course of year 3). Plans for establishing permanent STCs (or even staff training centres) at partner institutions will be outlined. Also first steps will be taken towards establishing a database or “pool” of STC courses which will be on offer for label applicants once the Label Association is up and running. A last TF2 meeting towards the end of the final project year will be used to assess the first draft of TF2 guidelines and to further valorize lessons learned during the project period. All TF members will be invited to report on activities carried out and progress made in the establishment of the permanent STCs / centres at the partner institutions. In the course of year 3 the STC guidelines will be finalized and published along with a database of STC information and contacts. Thus it is hoped that the STCs/ training centres established in year 3 will continue to operate beyond the project’s contract period Drafted by the Head of TF2 : Rachel Seeling (Berlin)

Task Force 3 ‘Autonomy and Accountability’
TF Aims and Plans for the 3rd Project Year During project year 3 the task force will primarily focus on implementation issues related to the IMS label. A Manual for the IMS Label During the second project year Task Force 3 (TF3) reviewed the qualitative IMS indicators suggested by TF1. As a result of this process it became evident that a manual with detailed background information for each indicator is vital for the success of the IMS label. The best practice examples identified by TF3 will be used to define full achievement for a particular indicator. An accompanying glossary will help to build a common terminology. The manual will support evaluators to provide a fair and transparent assessment of applicant institutions. Nevertheless, it will also serve as an inspiration and guideline to medical schools aiming to become more international. Autonomy and the IMS Label TF3 will develop a questionnaire to assess the degree of autonomy of a medical school. This questionnaire shall serve two purposes: (i) to gather data from our partners on their organizational structure with regards to autonomy and (ii) to determine the degree of autonomy of applicant institutions as part of their self-assessment during the application process. After the degree of autonomy (DoA) of a given institution has been assessed, a correction factor will be employed to account for different DoA when evaluating the indicators. For this purpose TF3 will identify indicators that are affected by any dimension of autonomy (financial, strategic, academic, staff etc.). Once the indicators concerning autonomy become evident, the correction factor will be used for the evaluation of the indicators thus compensating different DoA. Internal Testing and Evaluation of the Labelling Process TF3 will devote the final project year to the implementation of the label. One of the most important issues before the project period expires and before the IMS 2020 label comes onto the market is to test the label. The labelling process has already been defined by the IMS methodology paper and a great deal of effort has been put into the development of elaborated and reasonable indicators. A test site visit will turn theory into practice. TF3 suggests visiting one or two partner institutions to test the IMS 2020 labelling process. The test site visits will undergo an internal evaluation process. Drafted by the co-Head of TF3: Thomas Schlabs (Berlin) _________________________________________________________________________ For further information please take a look at the IMS 2020 project website: www.ims-2020.eu Or contact the IMS 2020 Project Coordinator, Ulrike Arnold a t ulrike.arnold@charite.de or the IMS 2020 Project Manager, Rachel Seeling at rachel.seeling@charite.de

Annex 1: Task Force Composition
TF 1 ‘Quality Assurance’ Member: Thomas Schlabs Uwe Brandenburg Britta Morzick Sophie Prima Marie-Madeleine Couttenye Cristiano Violani Joanna Gajowniczek Helena Salminen Ben Canny Institution: Charité Universitätsmedizin (DE) CHE Consult (DE) Université Paris Descartes (FR) Universiteit Antwerpen (BE) Sapienza Università di Roma (IT) Warszawski Uniwersytet Medyczny (PL) Karolinska Institutet (SE) Monash University Melbourne (AU) Function: Member TF leader Member Member Member Member Co-Leader Member Member

TF 2 ‘Staff Management & Training’ Member: Rachel Seeling Lutz Steiner Hannah Leichsenring Sophie Prima David Kums Griet Peeraer Massimo Levrero Lidia Przepióra Anna Urbanska Lars Smedman Sapienza Università di Roma (IT) Warszawski Uniwersytet Medyczny (PL) Karolinska Institutet (SE) TF member TF member Institution: Charité Universitätsmedizin Berlin (DE) CHE Consult (DE) Université Paris Descartes (FR) Universiteit Antwerpen (BE) Function: TF leaders

CHE consultant TF member TF member

TF member

TF 3 ‘Autonomy and Accountability’ Member: Magnus Rüde Thomas Schlabs Institution: Charité Universitätsmedizin (DE) Charité Universitätsmedizin Function: TF member TF Co-Leader

(DE) Andrea Güttner Claire Le Jeune Karel Van Liempt Annrita Vestri Malgorzata Rejnik Hans Gyllenhammar CHE Consult (DE) Université Paris Descartes (FR) Universiteit Antwerpen (BE) Sapienza Università di Roma (IT) Warszawski Uniwersytet Medyczny (PL) Karolinska Institutet (SE) TF Member TF Member TF Leader TF Member TF Member TF Member

Annex 2: Steering Committee Contacts:

Ulrike Arnold Karel Van liempt Claire Le Jeunne Lidia Przepiora Luciana Saso Helena Salminen Koen Delaere Uwe Brandenburg Ben Canny

Charité Universitätsmedizin Berlin Universiteit Antwerpen Université Paris Descartes

ulrike.arnold@charite.de karel.vanliempt@ua.ac.be claire.le-jeunne@htd.aphp.fr

Warszawski Uniwersytet Medyczny lidia.przepiora@wum.edu.pl Sapienza Università di Roma Karolinska Institutet Brussels Education Services CHE Consult University of Monash luciano.saso@uniroma1.it helena.salminen@ki.se delaere@eduser.be uwe.brandenburg@CHEConsult.de ben.canny@monash.edu

Berlin, 12th Oct 2012